Aozhou Wu

1.7k total citations · 1 hit paper
45 papers, 1.0k citations indexed

About

Aozhou Wu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Aozhou Wu has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Aozhou Wu's work include Dementia and Cognitive Impairment Research (6 papers), Nutritional Studies and Diet (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Aozhou Wu is often cited by papers focused on Dementia and Cognitive Impairment Research (6 papers), Nutritional Studies and Diet (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Aozhou Wu collaborates with scholars based in United States, China and Canada. Aozhou Wu's co-authors include Thomas H. Mosley, Rebecca F. Gottesman, David S. Knopman, Josef Coresh, Alden L. Gross, B. Gwen Windham, Keenan A. Walker, Elizabeth Selvin, Melinda C. Power and A. Richey Sharrett and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Aozhou Wu

40 papers receiving 1.0k citations

Hit Papers

Association of Midlife to Late-Life Blood Pressure Patter... 2019 2026 2021 2023 2019 50 100 150 200

Peers

Aozhou Wu
Jianzhao Xu United States
Emer R. McGrath United States
T. M. Greenaway Australia
Xia Zhou China
Aozhou Wu
Citations per year, relative to Aozhou Wu Aozhou Wu (= 1×) peers Emmanuelle Duron

Countries citing papers authored by Aozhou Wu

Since Specialization
Citations

This map shows the geographic impact of Aozhou Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aozhou Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aozhou Wu more than expected).

Fields of papers citing papers by Aozhou Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aozhou Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aozhou Wu. The network helps show where Aozhou Wu may publish in the future.

Co-authorship network of co-authors of Aozhou Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Aozhou Wu. A scholar is included among the top collaborators of Aozhou Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aozhou Wu. Aozhou Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tangri, Navdeep, Rakesh K. Singh, Yan Chen, et al.. (2025). Change in urine albumin-to-creatinine ratio and clinical outcomes in patients with chronic kidney disease and type 2 diabetes. BMJ Open Diabetes Research & Care. 13(5). e004854–e004854.
2.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). RSV Testing Patterns and Characteristics Associated with RSV Testing Among Adults Aged 50 Years or Older in the United States. Infectious Diseases and Therapy. 14(10). 2321–2340.
3.
Singer, David, Yan Wang, Aozhou Wu, et al.. (2025). P-686. Risk of COPD Exacerbations, Asthma Exacerbations, and Hospitalizations for Heart Failure after RSV Hospitalization Among US Adults Aged at Least 50 Years. Open Forum Infectious Diseases. 12(Supplement_1). 2 indexed citations
4.
Wu, Aozhou, et al.. (2025). Outpatient Process Transformation and Patient Satisfaction Under New Public Service Theory. Patient Preference and Adherence. Volume 19. 3349–3361.
6.
Stenehjem, David D., Solomon J. Lubinga, Aozhou Wu, & Keith A. Betts. (2023). Adverse event costs associated with first-line therapy for advanced non–small cell lung cancer in the United States: An analysis of clinical trials of immune checkpoint inhibitors. Journal of Managed Care & Specialty Pharmacy. 29(9). 1054–1064. 2 indexed citations
7.
Chen, Chongshu, et al.. (2023). Indirect treatment comparison (ITC) of the efficacy of vutrisiran and tafamidis for hereditary transthyretin-mediated amyloidosis with polyneuropathy. Expert Opinion on Pharmacotherapy. 24(10). 1205–1214. 5 indexed citations
9.
Gottesman, Rebecca F., Aozhou Wu, Josef Coresh, et al.. (2022). Associations of Vascular Risk and Amyloid Burden with Subsequent Dementia. Annals of Neurology. 92(4). 607–619. 16 indexed citations
10.
Scheppach, Johannes B., Aozhou Wu, Rebecca F. Gottesman, et al.. (2022). Association of Kidney Function Measures With Signs of Neurodegeneration and Small Vessel Disease on Brain Magnetic Resonance Imaging: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Kidney Diseases. 81(3). 261–269.e1. 22 indexed citations
11.
Mullins, C. Daniel, Kevin M. Pantalone, Keith A. Betts, et al.. (2022). CKD Progression and Economic Burden in Individuals With CKD Associated With Type 2 Diabetes. Kidney Medicine. 4(11). 100532–100532. 12 indexed citations
12.
Sharma, Richa, Kunihiro Matsushita, Aozhou Wu, et al.. (2021). Common Medications and Intracerebral Hemorrhage: The ARIC Study. Journal of the American Heart Association. 10(5). e014270–e014270. 8 indexed citations
13.
Tin, Adrienne, Keenan A. Walker, Jan Bressler, et al.. (2021). Association between Circulating Protein C Levels and Incident Dementia: The Atherosclerosis Risk in Communities Study. Neuroepidemiology. 55(4). 306–315. 4 indexed citations
14.
Östör, Andrew J.K., et al.. (2021). Value of Remission in Patients with Rheumatoid Arthritis: A Targeted Review. Advances in Therapy. 39(1). 75–93. 13 indexed citations
16.
Scheppach, Johannes B., Josef Coresh, Aozhou Wu, et al.. (2020). Albuminuria and Estimated GFR as Risk Factors for Dementia in Midlife and Older Age: Findings From the ARIC Study. American Journal of Kidney Diseases. 76(6). 775–783. 41 indexed citations
17.
Wu, Aozhou, et al.. (2020). Associations of serum uric acid with incident dementia and cognitive decline in the ARIC-NCS cohort. Journal of the Neurological Sciences. 414. 116866–116866. 25 indexed citations
18.
Power, Melinda C., Aozhou Wu, Robert I. Reid, et al.. (2019). Association of white matter microstructural integrity with cognition and dementia. Neurobiology of Aging. 83. 63–72. 39 indexed citations
19.
Liu, Shuiqing, Esther D. Kim, Aozhou Wu, et al.. (2019). Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults. PLoS ONE. 14(2). e0212892–e0212892. 19 indexed citations
20.
Herzog, Charles A., Aozhou Wu, Yingying Sang, et al.. (2016). Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrology. 17(1). 18–18. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026